ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
CBD tablet significantly improves diabetic peripheral neuropathic pain
May 18, 2021In a Phase II trial, a cannabidiol (CBD) sublingual tablet reduced pain scores in patients with diabetic peripheral neuropathy by approximately 50 percent. -
Novaremed seeks FDA nod for evaluating NRD135S.E1 for treatment of PDPN
May 28, 2020Novaremed is seeking the approval of the US Food and Drug Administration (FDA) to begin a phase 2 trial for evaluating its new drug candidate NRD135S.E1 for the treatment of painful diabetic peripheral neuropathy (PDPN).
Pharma Sources Insight January 2025
